Brind.
Entities  /  Company

Hoffmann-La Roche.

Swiss healthcare company

Seen in 235 reportsLast reported Nov 12

Reports this week
0
Active events
1
Connections
951

What's happening

Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday

Earlier this month

One to three months ago

What's reaching Hoffmann-La Roche

Events traced to Hoffmann-La Roche, step by step, newest first

Explainers that pass through Hoffmann-La Roche

Hoffmann-La Roche is a step on the way to someone else

Around Hoffmann-La Roche this week

News at the entities that move Hoffmann-La Roche most

Connections

The 40 strongest of 951, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.
Show all 40 connections
  • LabCorp Structural

    LabCorp utilizes companion diagnostic tests provided by Hoffmann-La Roche for prostate cancer testing.

    Well supportedSep 5
  • The partnership between Roche and the National Cancer Centre Singapore is focused on leveraging combined expertise to accelerate precision medicine research.

    Some supportAug 31
  • Sarepta Therapeutics Operational

    Sarepta Therapeutics and Hoffmann-La Roche are actively collaborating on the development and contract manufacturing of the Elevidys gene therapy.

    Some supportAug 6
  • Zymeworks Structural

    Roche and Zymeworks have a collaboration agreement where Roche funds and develops ZW209.

    Some supportOct 23
  • Alnylam and Roche maintain an ongoing operational partnership involving joint drug development and milestone payments.

    Some supportJul 2
  • Merck Operational

    Roche and Merck are direct competitors in the immuno-oncology and PD-L1 inhibitor markets.

    Some supportSep 24
  • Paulo Fontoura Structural

    Paulo Fontoura was employed by Hoffmann-La Roche for 15 years.

    Some supportJun 23
  • Herbert Boyer Structural

    Hoffmann-La Roche's current research and products are founded upon the specific DNA cutting research conducted by Herbert Boyer.

    Some supportJul 27
  • Basilea Pharmaceutica was established as a spin-off from Hoffmann-La Roche.

    Some supportSep 26
  • Hoffmann-La Roche and Lineage Cell Therapeutics maintain an exclusive worldwide collaboration for the development and optimization of the OpRegen therapy.

    Some supportAug 9
  • Eli Lilly and Company Operational

    Hoffmann-La Roche and Eli Lilly and Company are actively collaborating on product development, securing joint market authorizations, and participating in test launches.

    Well supportedSep 5
  • The Medicines Patent Pool holds a voluntary licensing agreement with Hoffmann-La Roche.

    Well supportedOct 8
  • Exelixis Operational

    Exelixis utilizes Roche's Tecentriq product as part of a combined therapeutic approach.

    Some supportSep 11
  • Nvidia Operational

    The entities maintain an active operational collaboration focused on developing AI-driven therapeutics and biotech.

    Some supportSep 26
  • Hanmi Pharmaceutical holds a licensing agreement with Roche Group for its obesity drug.

    Some supportAug 26
  • Hoffmann-La Roche was founded based on research conducted at the University of California.

    Some supportJul 27
  • Omar Khwaja Structural

    Omar Khwaja held senior roles at Hoffmann-La Roche.

    Some supportNov 12
  • Biogen Structural

    Biogen receives royalties from drugs developed by Hoffmann-La Roche.

    Some supportOct 6
  • Astex Pharmaceuticals Transactional

    Exclusive license granted for breast cancer compounds.

    Some supportJul 6
  • The FDA formally cleared Roche's blood test for Alzheimer's, establishing a regulatory dependency.

    Some supportAug 28
  • Johnson & Johnson Operational

    Roche and Johnson & Johnson are actively competing in the oncology and generalized myasthenia gravis markets.

    Some supportJul 5
  • JAMA Structural

    Hoffmann-La Roche utilizes JAMA as a peer-reviewed platform for publishing studies that support its test development.

    Some supportAug 28
  • SGH provides testing services and samples to Hoffmann-La Roche for drug development.

    Some supportJul 2
  • OraSure supplies testing kits that are utilized by Hoffmann-La Roche for its procedures.

    Some supportSep 7
  • GSK Operational

    The two companies are actively competing in the market, specifically regarding lung cancer treatments.

    Some supportJun 11
  • Allston Structural

    Hoffmann-La Roche is establishing a research hub in Allston.

    Some supportSep 23
  • Novartis Operational

    The companies actively compete in the global pharmaceutical sector, having previously completed a divestiture transaction.

    Well supportedOct 29
  • Genotek Structural

    Genotek provides kits that are utilized by Hoffmann-La Roche for molecular testing.

    Some supportJun 11
  • Bristol-Myers Squibb Operational

    Both companies are direct competitors in the pharmaceutical market, offering drugs for lung cancer and facing comparative market pressures.

    Some supportSep 20
  • Kazakhstan Structural

    Hoffmann-La Roche maintains a functional presence in Kazakhstan through ongoing local production projects.

    Some supportAug 28
  • Ivana Structural

    Ivana gained professional experience while employed at Hoffmann-La Roche.

    Some supportOct 6
  • Ionis Pharmaceuticals Transactional

    Roche terminated the drug development partnership it held with Ionis Pharmaceuticals.

    Some supportOct 10

History

Events by the month they began

October 2026

19 events

September 2026

17 events
Show 3 earlier months